Maestros Electronics & Telecommun. Systems Ltd
Incorporated in 2010, Maestros Electronics & Telecommunications Systems Ltd is in the business of Electronics & Instrumentation (E&T) and Telemedicine[1]
- Market Cap ₹ 78.9 Cr.
- Current Price ₹ 143
- High / Low ₹ 262 / 113
- Stock P/E 18.1
- Book Value ₹ 63.3
- Dividend Yield 0.00 %
- ROCE 16.6 %
- ROE 13.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Debtor days have improved from 108 to 44.3 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.2.46 Cr.
- Promoter holding has decreased over last 3 years: -8.19%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| 33.29 | 28.91 | |
| 26.93 | 24.81 | |
| Operating Profit | 6.36 | 4.10 |
| OPM % | 19.10% | 14.18% |
| 1.80 | 2.46 | |
| Interest | 0.80 | 0.48 |
| Depreciation | 0.45 | 0.39 |
| Profit before tax | 6.91 | 5.69 |
| Tax % | 28.51% | 23.20% |
| 4.94 | 4.37 | |
| EPS in Rs | 8.97 | 7.93 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 20% |
| 3 Years: | 39% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Equity Capital | 5.51 | 5.51 |
| Reserves | 25.02 | 29.36 |
| 5.35 | 3.59 | |
| 21.39 | 20.57 | |
| Total Liabilities | 57.27 | 59.03 |
| 8.44 | 9.66 | |
| CWIP | 3.48 | 4.93 |
| Investments | 0.00 | 0.00 |
| 45.35 | 44.44 | |
| Total Assets | 57.27 | 59.03 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 172.36 | 44.32 |
| Inventory Days | 111.83 | 142.46 |
| Days Payable | 73.40 | 85.52 |
| Cash Conversion Cycle | 210.78 | 101.25 |
| Working Capital Days | 22.26 | -20.33 |
| ROCE % | 16.60% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
31 May - Copies of newspaper publications published today respect to Audited Financial Results for the Quarter and Financial Year ended March 31, 2025
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report filed for FY ended March 31, 2025 as per SEBI regulations.
-
Announcement under Regulation 30 (LODR)-Change in Management
29 May - Approved FY25 audited financials with clean audit opinion; appointed new internal and secretarial auditors.
-
Announcement under Regulation 30 (LODR)-Change in Management
29 May - Approved FY25 audited financials with unmodified opinion; appointed internal and secretarial auditors for FY26.
-
Audited Standalone And Consolidated Financial Statements And Results For The Quarter And Financial Year Ended March 31, 2025
29 May - Audited FY25 results approved with unmodified opinion; new internal and secretarial auditors appointed.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
Business Overview:[1]
Company is a design, development and manufacturing company which creates
products and services for financial inclusion, cardiology, gynecology, critical care patient
and diseases management in medicine. It specializes in Medical device manufacturing, Telemedicine and Healthcare Solutions and Business Automation (Banking and Micro finance, financial inclusion, PDS automation)